*ST生物
(000504)
| 流通市值：30.21亿 | | | 总市值：30.30亿 |
| 流通股本：3.29亿 | | | 总股本：3.30亿 |
| 报告期 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 183,374,413.22 | 346,768,170.11 | 162,818,548.64 | 140,177,370.21 |
| 交易性金融资产 | 120,000,583.03 | - | 100,456,626 | 165,461,994 |
| 应收票据及应收账款 | 350,586,689.91 | 320,479,476.74 | 143,513,365.48 | 122,942,037.32 |
| 其中：应收票据 | 186,311,545.08 | 101,958,952.44 | 5,300,000 | - |
| 应收账款 | 164,275,144.83 | 218,520,524.3 | 138,213,365.48 | 122,942,037.32 |
| 应收款项融资 | - | - | - | 12,000,000 |
| 预付款项 | 26,741,689.45 | 15,630,255.18 | 15,257,131.58 | 5,796,270.28 |
| 其他应收款合计 | 17,652,512.15 | 18,021,005.54 | 24,013,242.66 | 11,203,966.16 |
| 存货 | 48,538,088.3 | 18,665,612.89 | 46,254,810.61 | 18,191,314.08 |
| 其他流动资产 | 20,162,236.68 | 19,355,287.56 | 25,123,158.83 | 12,405,451.29 |
| 流动资产合计 | 767,056,212.74 | 738,919,808.02 | 517,436,883.8 | 488,178,403.34 |
| 非流动资产: | | | | |
| 固定资产 | 163,516,792 | 165,435,181.41 | 148,431,703.5 | 12,777,137.46 |
| 在建工程 | 1,381,954.45 | 108,075.33 | 19,519,761.87 | - |
| 使用权资产 | 4,180,077.71 | 4,677,762.89 | 8,508,211.67 | 9,198,389.09 |
| 无形资产 | 55,549,826.18 | 55,811,301.22 | 62,365,426.98 | 2,343,686.15 |
| 商誉 | 6,226,910.53 | 6,226,910.53 | 1,983,226.77 | 1,983,226.77 |
| 长期待摊费用 | 9,803,899.4 | 10,833,889.63 | 75,395,629.43 | 77,923,846.47 |
| 递延所得税资产 | 8,708,420.46 | 8,708,420.46 | 8,280,946.43 | 2,650,293.48 |
| 其他非流动资产 | - | 1,009,654.27 | 34,185.07 | 34,185.07 |
| 非流动资产合计 | 249,367,880.73 | 252,811,195.74 | 324,519,091.72 | 106,910,764.49 |
| 资产总计 | 1,016,424,093.47 | 991,731,003.76 | 841,955,975.52 | 595,089,167.83 |
| 流动负债: | | | | |
| 短期借款 | 278,407,812.64 | 270,254,392.59 | 43,041,722.22 | - |
| 应付票据及应付账款 | 14,395,013.11 | 14,715,783.6 | 94,693,650.09 | 86,564,550.62 |
| 其中：应付票据 | - | - | 11,424,016.81 | - |
| 应付账款 | 14,395,013.11 | 14,715,783.6 | 83,269,633.28 | 86,564,550.62 |
| 预收款项 | - | - | 21,895.84 | - |
| 合同负债 | 206,833,526.31 | 201,445,948.34 | 194,605,702.35 | 195,543,246.23 |
| 应付职工薪酬 | 3,953,171.65 | 7,739,934.25 | 3,227,495.57 | 3,952,021.09 |
| 应交税费 | 4,354,752.91 | 15,358,316.65 | 2,702,493.75 | 1,096,020.89 |
| 其他应付款合计 | 21,498,369.94 | 8,511,967.53 | 8,090,172.42 | 3,711,128.99 |
| 应付股利 | 931,102.81 | 931,102.81 | 931,102.81 | 931,102.81 |
| 一年内到期的非流动负债 | 13,099,091.09 | 14,801,206.97 | 1,580,959.99 | 4,597,088.2 |
| 其他流动负债 | 12,223,756.48 | 12,327,796.48 | 16,393,819.61 | 14,474,704.27 |
| 流动负债合计 | 554,765,494.13 | 545,155,346.41 | 364,357,911.84 | 309,938,760.29 |
| 非流动负债: | | | | |
| 长期借款 | 52,950,000 | 52,950,000 | 75,485,000 | 8,500,000 |
| 租赁负债 | 5,225,889.34 | 3,235,879.48 | 9,676,004.43 | 7,394,822.88 |
| 递延收益 | 27,304,549.12 | 26,641,263.45 | 23,152,257.04 | 1,465,906.2 |
| 递延所得税负债 | 6,242,222.94 | 6,242,192.96 | 6,628,814.59 | 87,610.83 |
| 其他非流动负债 | 863,767.78 | - | - | - |
| 非流动负债合计 | 92,586,429.18 | 89,069,335.89 | 114,942,076.06 | 17,448,339.91 |
| 负债合计 | 647,351,923.31 | 634,224,682.3 | 479,299,987.9 | 327,387,100.2 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 330,023,098 | 330,023,098 | 330,023,098 | 330,023,098 |
| 资本公积 | 423,300,174.6 | 423,300,174.6 | 423,472,870.01 | 423,472,870.01 |
| 盈余公积 | 34,545,734.18 | 34,545,734.18 | 34,545,734.18 | 34,545,734.18 |
| 未分配利润 | -511,017,154.16 | -522,117,836.05 | -545,714,187.56 | -554,430,935.04 |
| 归属于母公司股东权益合计 | 276,851,852.62 | 265,751,170.73 | 242,327,514.63 | 233,610,767.15 |
| 少数股东权益 | 92,220,317.54 | 91,755,150.73 | 120,328,472.99 | 34,091,300.48 |
| 股东权益合计 | 369,072,170.16 | 357,506,321.46 | 362,655,987.62 | 267,702,067.63 |
| 负债和股东权益合计 | 1,016,424,093.47 | 991,731,003.76 | 841,955,975.52 | 595,089,167.83 |
| 公告日期 | 2026-04-29 | 2026-04-29 | 2025-10-27 | 2025-08-28 |
| 审计意见(境内) | | 标准无保留意见 | | |